MS vs PACB · P/E 20, $344.27B cap vs rev $38.4M
Morgan Stanley (MS) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
MS does not have a complete income-statement cache yet.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
MS currently screens at market cap $344.27B and trailing P/E 19.8. PACB currently screens at market cap $387.1M.
Not investment advice. Open the MS and PACB stock pages for the full models.
Not investment advice.